Oral anticoagulation in patients with atrial fibrillation and advanced chronic kidney disease: additional kidney benefits beyond stroke prevention

被引：0
|
作者：
Kreutz, Reinhold [1 ,2 ,3 ,4 ]
机构：
[1] Charite Univ Med Berlin, Inst Clin Pharmacol & Toxicol, Charitepl 1, D-10117 Berlin, Germany
[2] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany
[3] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany
[4] Berlin Inst Hlth, Charite Campus Mitte, Charitepl 1, D-10117 Berlin, Germany
来源：
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ | 2024年 / 134卷 / 11期
关键词：
VITAMIN-K ANTAGONISTS; RENAL-FUNCTION; OUTCOMES; RISK;
D O I：
10.20452/pamw.16892
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The importance of oral anticoagulation in patients with atrial fibrillation for stroke prevention
    Neundoerfer, B.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2008, 76 (07) : 383 - 384
  • [32] Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist’s perspective
    Maura Ravera
    Elisabetta Bussalino
    Maria Fusaro
    Luca Di Lullo
    Filippo Aucella
    Ernesto Paoletti
    Journal of Nephrology, 2020, 33 : 483 - 495
  • [33] Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease
    Potpara, Tatjana S.
    Jokic, Vera
    Dagres, Nikolaos
    Larsen, Torben B.
    Lane, Deirdre A.
    Hindricks, Gerhard
    Lip, Gregory Y. H.
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (19) : 2055 - 2069
  • [34] Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist's perspective
    Ravera, Maura
    Bussalino, Elisabetta
    Fusaro, Maria
    Di Lullo, Luca
    Aucella, Filippo
    Paoletti, Ernesto
    JOURNAL OF NEPHROLOGY, 2020, 33 (03) : 483 - 495
  • [35] Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study
    Montomoli, Marco
    Roca, Lourdes
    Rivera, Mariana
    Fernandez-Prado, Raul
    Redondo, Beatriz
    Camacho, Rosa
    Moyano, Cayetana
    Pampa, Saul
    Gonzalez, Angela
    Casas, Juan
    Kislikova, Maria
    Sanchez Horrillo, Ana
    Cabrera Cardena, Alicia
    Quiroga, Borja
    Rabasco, Cristina
    Piqueras, Sara
    Suso, Andrea
    Reque, Javier
    Villa, Juan
    Ojeda, Raquel
    Arroyo, David
    HEALTHCARE, 2022, 10 (12)
  • [36] Stroke prevention in patients with atrial fibrillation and chronic kidney disease in stage 4 or stage 5
    Petricciuolo, Serena
    Aimo, Alberto
    De Caterina, Raffaele
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (01) : 6 - 15
  • [37] Prevention of stroke in patients with atrial fibrillation and chronic kidney disease: difficult choices and clinical decisions
    Gorczyca-Michta, Iwona
    Kluk, Maciej
    Wozakowska-Kaplon, Beata
    KARDIOLOGIA POLSKA, 2012, 70 (09) : 948 - 952
  • [38] Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease
    Yang, Felix
    Hellyer, Jessica A.
    Than, Claire
    Ullal, Aditya J.
    Kaiser, Daniel W.
    Heidenreich, Paul A.
    Hoang, Donald D.
    Winkelmayer, Wolfgang C.
    Schmitt, Susan
    Frayne, Susan M.
    Phibbs, Ciaran S.
    Turakhia, Mintu P.
    HEART, 2017, 103 (11) : 818 - 826
  • [39] The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease
    Mace-Brickman, Trevor
    Eddeen, Anan Bader
    Carrero, Juan-Jesus
    Mark, Patrick B.
    Molnar, Amber O.
    Lam, Ngan N.
    Zimmerman, Deborah
    Harel, Ziv
    Sood, Manish M.
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2019, 6
  • [40] Oral anticoagulation in patients with chronic kidney disease
    Malhotra, Konark
    Ishfaq, Muhammad F.
    Goyal, Nitin
    Katsanos, Aristeidis H.
    Parissis, John
    Alexandrov, Anne W.
    Alexandrov, Andrei V.
    Tsivgoulis, Georgios
    NEUROLOGY, 2019, 92 (21) : E2421 - E2431
12345